Subject: Science And Tech | Published: 17 November 2025
India's immunization revolution: from traditional vaccines to mrna frontiers
Recommended UPSC Book List
Access the curated list of standard books and resources used by top aspirants for all subjects.
The Foundation: Understanding Immunity
The human body’s defense mechanism, the immune system, is a complex network that protects against disease-causing pathogens. It operates on a dual-nature principle: Innate Immunity and Acquired (or Adaptive) Immunity. Innate immunity is the body’s non-specific, first line of defense, present from birth. In contrast, acquired immunity is a specific defense that develops over time after exposure to an antigen (a foreign substance) or through vaccination. This adaptive response has two primary arms: humoral immunity, mediated by antibodies produced by B-cells, and cell-mediated immunity, driven by T-cells. A key component of this system is the Major Histocompatibility Complex (MHC), a group of genes that code for proteins found on the surfaces of cells that help the immune system recognize foreign substances.
Fun Fact: The word “vaccine” originates from the Latin word vacca, meaning cow. Edward Jenner, in 1796, used material from cowpox pustules to protect people from the deadlier smallpox, laying the groundwork for modern immunology.
The Pillars of Public Health: Immunization in India
Immunization is the most effective public health intervention to prevent infectious diseases. India’s commitment to this is embodied in the Universal Immunization Programme (UIP), launched in 1985. It is one of the largest public health programs in the world, targeting millions of newborns, children, and pregnant women annually.
A significant recent development is the 2024 announcement by the Indian government to roll out the Human Papillomavirus (HPV) vaccine through the UIP for girls aged 9-14. This is a monumental step towards eliminating cervical cancer, the second most common cancer among women in India.
To bolster the UIP, the government launched Mission Indradhanush in 2014. Its objective is to increase immunization coverage against vaccine-preventable diseases. The program has evolved through several phases, with the latest being Intensified Mission Indradhanush (IMI) 5.0, launched across all states/UTs in 2023. IMI 5.0’s primary goal is to identify and vaccinate all children up to 5 years of age and pregnant women who missed their vaccine doses, with a special focus on achieving over 90% full immunization coverage and sustaining it.
Captivating Stat: India’s pharmaceutical industry, often called the ‘Pharmacy of the World’, produces over 60% of the global vaccine supply, making it a linchpin in international health security.
The Arsenal: A Spectrum of Vaccine Technologies
Vaccines work by introducing a harmless version or piece of a pathogen to the immune system, training it to recognize and fight the real disease. Vaccine technologies have evolved significantly over the decades.
| Vaccine Category | Type | Mechanism & Examples |
|---|---|---|
| Traditional Vaccines | Live-Attenuated | Uses a weakened (attenuated) form of the live virus. Examples: Measles, Mumps, Rubella (MMR), Polio (oral). |
| Inactivated | Uses the killed version of the germ that causes a disease. Examples: Inactivated Polio Vaccine (IPV), Rabies. | |
| Subunit/Recombinant | Uses only specific pieces of the germ (like its protein or sugar). Examples: Hepatitis B, HPV. | |
| Toxoid | Uses a toxin (harmful product) made by the germ. Examples: Diphtheria, Tetanus. | |
| Modern Vaccines | mRNA (messenger RNA) | Teaches our cells how to make a protein that triggers an immune response. Examples: Pfizer-BioNTech & Moderna COVID-19 vaccines. |
| Viral Vector | Uses a modified version of a different, harmless virus (the vector) to deliver important instructions to our cells. Example: AstraZeneca/Covishield, Sputnik V. | |
| DNA Vaccines | Involves the direct introduction of a plasmid containing the DNA sequence encoding the antigen(s). Currently under advanced research for various diseases. |
Mnemonic for Key Modern Vaccine Platforms: Remember “MR. V”
- M - mRNA
- R - Recombinant (Subunit)
- V - Viral Vector
Critical Policy Appraisal
| Challenges / Criticisms | Opportunities / Successes / Way Forward |
|---|---|
| Vaccine Hesitancy: Misinformation and lack of awareness hinder uptake, especially in remote areas. | IMI 5.0: Targeted campaigns and community mobilization are actively countering hesitancy. |
| Logistical Gaps: Maintaining the cold chain for temperature-sensitive vaccines is a major challenge in a diverse geography. | eVIN (Electronic Vaccine Intelligence Network): A digital platform to track vaccine stocks and storage temperature in real-time, enhancing efficiency. |
| Equity Issues: Disparities in access between urban and rural areas, and rich and poor states, persist. | Vaccine Maitri: India’s global vaccine diplomacy during the COVID-19 pandemic showcased its production capacity and commitment to global health equity. |
| Emerging Pathogens: The threat of new pandemics requires a more agile R&D and manufacturing ecosystem. | National Biopharma Mission: A government initiative to foster an ecosystem for innovative biopharmaceutical development, including novel vaccines. |
Illustrative Analogy: Think of India’s cold chain network like a food delivery service for vaccines. Just as a pizza needs to arrive hot, a vaccine needs to arrive at the right temperature to be effective. The eVIN platform is like the GPS tracking app that ensures the delivery is on time and in perfect condition.
Analytical Lens: UPSC Focus (Mains & Prelims)
Conceptual Basis
The legal and constitutional foundation for India’s immunization programs is rooted in the Indian Constitution. Article 21 (Right to Life) has been interpreted by the Supreme Court to include the Right to Health. Furthermore, Article 47, a Directive Principle of State Policy, mandates the State to raise the level of nutrition and the standard of living and to improve public health, making immunization a core state responsibility.
UPSC Integration: Connecting the Dots
- Polity (GS Paper 2): Federalism (health is a state subject, but national policies drive the agenda), governance, and public service delivery mechanisms.
- Economy (GS Paper 3): The role of the pharmaceutical industry, intellectual property rights (IPR) related to vaccines, and public health expenditure.
- Science & Technology (GS Paper 3): Biotechnology, different vaccine platforms (mRNA, viral vector), and disease surveillance.
- International Relations (GS Paper 2): Global health diplomacy (e.g., Vaccine Maitri), the role of WHO and GAVI, and global pandemic preparedness treaties.
Expert Analysis: Future Outlook
The future of immunization in India hinges on three pillars: technology, equity, and preparedness. The success of mRNA platforms has opened doors for rapid development of vaccines against future pandemic threats and even non-communicable diseases like cancer. However, the key challenge will be to translate this technological prowess into equitable access for the last mile. Strengthening primary healthcare centers, leveraging digital tools like the U-WIN platform (a digital registry for all vaccinations), and fostering public-private partnerships for R&D will be critical. The long-term policy focus must be on creating a resilient health system that can not only manage routine immunization but also surge capacity during a crisis, truly embodying the principles of the Immunization Agenda 2030.
Prelims Practice Question (MCQ)
Question: Which of the following diseases is NOT covered under India’s Universal Immunization Programme (UIP)? a) Diphtheria b) Rubella c) Rotavirus Diarrhoea d) Hepatitis C
Answer: (d) Hepatitis C Explanation: The Universal Immunization Programme (UIP) provides vaccines for Diphtheria, Pertussis, Tetanus, Polio, Measles, Rubella, severe form of Childhood Tuberculosis, Hepatitis B, Meningitis & Pneumonia caused by Hemophilus influenzae type B, and Rotavirus Diarrhoea. While the Hepatitis B vaccine is part of the UIP, the vaccine for Hepatitis C is not currently included in the national schedule.
Mains Sample Question
Question (15 Marks): “While India has made significant strides in immunization coverage through initiatives like Mission Indradhanush, the COVID-19 pandemic exposed critical gaps in its public health infrastructure.” Critically analyze this statement. What strategic reforms are necessary to build a more resilient and equitable vaccination ecosystem for the future?
Mind Map Outline (Revision Structure)
- Immunology & Vaccines
- Core Concepts of Immunity
- Innate vs. Acquired (Adaptive) Immunity
- Humoral (B-cells, Antibodies)
- Cell-Mediated (T-cells)
- Key Components: MHC, Lymph, Blood
- Innate vs. Acquired (Adaptive) Immunity
- India’s Immunization Framework
- Constitutional Basis
- Article 21: Right to Health
- Article 47: Duty of State to improve public health
- Universal Immunization Programme (UIP)
- Objectives and covered diseases
- Mission Indradhanush:
- Phases and objectives
- IMI 5.0 (2023): Focus on zero-dose children
- New Developments (2024):
- Introduction of HPV vaccine for cervical cancer
- Constitutional Basis
- Vaccine Technology & Types
- Traditional Vaccines
- Live-Attenuated (e.g., MMR)
- Inactivated (e.g., IPV)
- Subunit (e.g., Hepatitis B)
- Toxoid (e.g., Tetanus)
- Modern Vaccines
- mRNA (e.g., Moderna)
- Viral Vector (e.g., Covishield)
- DNA Vaccines
- Traditional Vaccines
- Policy Analysis & Challenges
- Critical Appraisal
- Challenges: Vaccine Hesitancy, Cold Chain Logistics, Equity Gaps
- Successes: High Production, IMI, eVIN, Vaccine Maitri
- Global Context
- Role of WHO & GAVI
- Immunization Agenda 2030
- Critical Appraisal
- Core Concepts of Immunity